A lot of people assume that if PGT is available,
it should be the obvious choice.

Test the embryos.
Pick the normal one.
Increase the chances.

So choosing not to do it
can feel confusing.

“Why skip something that could help?”

But the decision isn’t always that simple.

For some, the number of embryos is already very limited.

One or two.

Sometimes even just one.

Then the question becomes different.

Not “which embryo is best”
but “can we afford to risk losing any?”

Because PGT involves testing and handling the embryo.

And while it provides information,
it also adds another step in the process.

So for some people,
the concern is not just about results.

It’s about what they might lose along the way.

Then does skipping PGT reduce chances?

Not necessarily in a straightforward way.

It shifts the approach.

From selecting before transfer
to seeing how things develop after.

This is why the same option
can feel right for one person
and not for another.

It’s not always about choosing the “best” method.

Sometimes it’s about choosing
what feels possible
within the situation they are in.